Cellular senescence controls fibrosis in wound healing

Aging

Volumn 2, Issue 9, 2010, Pages 627-631

  Jun, Joon Il ^a   Lau, Lester F ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

CCN1; Inflammation; Integrin; Senescence; Wound healing

Indexed keywords

CYSTEINE RICH PROTEIN 61;

ARTICLE; CELL AGING; CELL PROLIFERATION; CYTOLOGY; EXTRACELLULAR MATRIX; FIBROSIS; HUMAN; MYOFIBROBLAST; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; SKIN; WOUND HEALING;

CELL AGING; CELL PROLIFERATION; CYSTEINE-RICH PROTEIN 61; EXTRACELLULAR MATRIX; FIBROSIS; HUMANS; MYOFIBROBLASTS; OXIDATIVE STRESS; SKIN; WOUND HEALING;

EID: 79952115737     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100201     Document Type: Article

References (45)

1. Acosta JC, O'Loghlen A, Banito A, Guijarro MV, Augert A, Raguz S, Fumagalli M, Da CM, Brown C, Popov N, Takatsu Y, Melamed J, dda di FF, Bernard D, Hernando E, Gil J. Chemokine signaling via the CXCR2 receptor reinforces senescence. Cell. 2008, 133:1006-1018.
2. Bataller R, Brenner DA. Liver fibrosis. J Clin Invest. 2005, 115:209-218.
3. Braig M, Lee S, Loddenkemper C, Rudolph C, Peters AH, Schlegelberger B, Stein H, Dorken B, Jenuwein T, Schmitt CA. Oncogene-induced senescence as an initial barrier in lymphoma development. Nature. 2005, 436:660-665.
4. Campisi J, d'Adda di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007, 8:729-740.
5. Castro P, Giri D, Lamb D, Ittmann M. Cellular senescence in the pathogenesis of benign prostatic hyperplasia. Prostate. 2003, 55:30-38.
6. Chan JC, Duszczyszyn DA, Castellino FJ, Ploplis VA. Accelerated skin wound healing in plasminogen activator inhibitor-1- deficient mice. Am J Pathol. 2001, 159:1681-1688.
7. Chen C-C, Lau LF. Functions and Mechanisms of Action of CCN Matricellular Proteins. Int J Biochem Cell Biol. 2009, 41:771-783.
8. Chen C-C, Mo F-E, Lau LF. The angiogenic inducer Cyr61 induces a genetic program for wound healing in human skin fibroblasts. J Biol Chem. 2001, 276:47329-47337.
9. Chen Z, Trotman LC, Shaffer D, Lin HK, Dotan ZA, Niki M, Koutcher JA, Scher HI, Ludwig T, Gerald W, Cordon-Cardo C, Pandolfi PP. Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis. Nature. 2005, 436:725-730.
10. Collado M, Blasco MA, Serrano M. Cellular senescence in cancer and aging. Cell. 2007, 130:223-233.
11. Coppe JP, Desprez PY, Krtolica A, Campisi J. The senescenceassociated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 2010, 5:99-118.
12. Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP, Goldstein J, Nelson PS, Desprez PY, Campisi J. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008, 6:2853-2868.
13. Courtois-Cox S, Genther Williams SM, Reczek EE, Johnson BW, McGillicuddy LT, Johannessen CM, Hollstein PE, MacCollin M, Cichowski K. A negative feedback signaling network underlies oncogene-induced senescence. Cancer Cell. 2006, 10:459-472.
14. Darby IA, Hewitson TD. Fibroblast differentiation in wound healing and fibrosis. Int Rev Cytol. 2007, 257:143-179.
15. Eming SA, Krieg T, Davidson JM. Inflammation in wound repair: molecular and cellular mechanisms. J Invest Dermatol. 2007, 127:514-525.
16. Erusalimsky JD, Kurz DJ. Cellular senescence in vivo: its relevance in ageing and cardiovascular disease. Exp Gerontol. 2005, 40:634-642.
17. Gallucci RM, Simeonova PP, Matheson JM, Kommineni C, Guriel JL, Sugawara T, Luster MI. Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice. FASEB J. 2000, 14:2525-2531.
18. Gurtner GC, Werner S, Barrandon Y, Longaker MT. Wound repair and regeneration. Nature. 2008, 453:314-321.
19. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res. 1965, 37:614-636.
20. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res. 1961, 25:585-621.
21. Iocono JA, Colleran KR, Remick DG, Gillespie BW, Ehrlich HP, Garner WL. Interleukin-8 levels and activity in delayed-healing human thermal wounds. Wound Repair Regen. 2000, 8:216-225.
22. Jun J-I, Lau LF. The Matricellular Protein CCN1/CYR61 Induces Fibroblast Senescence and Restricts Fibrosis in Cutaneous Wound Healing. Nat Cell Biol. 2010, 12:676-685.
23. Kim KS, Seu YB, Baek SH, Kim MJ, Kim KJ, Kim JH, Kim JR. Induction of cellular senescence by insulin-like growth factor binding protein-5 through a p53-dependent mechanism. Mol Biol Cell. 2007, 18:4543-4552.
24. Kortlever RM, Higgins PJ, Bernards R. Plasminogen activator inhibitor-1 is a critical downstream target of p53 in the induction of replicative senescence. Nat Cell Biol. 2006, 8:877-884.
25. Krizhanovsky V, Xue W, Zender L, Yon M, Hernando E, Lowe SW. Implications of Cellular Senescence in Tissue Damage Response, Tumor Suppression, and Stem Cell Biology. Cold Spring Harb Symp Quant Biol. 2008, 73:513-522.
26. Krizhanovsky V, Yon M, Dickins RA, Hearn S, Simon J, Miething C, Yee H, Zender L, Lowe SW. Senescence of activated stellate cells limits liver fibrosis. Cell. 2008, 134:657-667.
27. Kuilman T, Michaloglou C, Vredeveld LC, Douma S, van DR, Desmet CJ, Aarden LA, Mooi WJ, Peeper DS. Oncogene-induced senescence relayed by an interleukin-dependent inflammatory network. Cell. 2008, 133:1019-1031.
28. Kuilman T, Peeper DS. Senescence-messaging secretome: SMS-ing cellular stress. Nat Rev Cancer. 2009, 9:81-94.
29. Michaloglou C, Vredeveld LC, Soengas MS, Denoyelle C, Kuilman T, van der Horst CM, Majoor DM, Shay JW, Mooi WJ, Peeper DS. BRAFE600-associated senescence-like cell cycle arrest of human naevi. Nature. 2005, 436:720-724.
30. Minamino T, Komuro I. Vascular cell senescence: contribution to atherosclerosis. Circ Res. 2007, 100:15-26.
31. Muller M. Cellular senescence: molecular mechanisms, in vivo significance, and redox considerations. Antioxid Redox Signal. 2009, 11:59-98.
32. Passino MA, Adams RA, Sikorski SL, Akassoglou K. Regulation of hepatic stellate cell differentiation by the neurotrophin receptor p75NTR. Science. 2007, 315:1853-1856.
33. Price JS, Waters JG, Darrah C, Pennington C, Edwards DR, Donell ST, Clark IM. The role of chondrocyte senescence in osteoarthritis. Aging Cell. 2002, 1:57-65.
34. Scurr LL, Pupo GM, Becker TM, Lai K, Schrama D, Haferkamp S, Irvine M, Scolyer RA, Mann GJ, Becker JC, Kefford RF, Rizos H. IGFBP7 is not required for B-RAF-induced melanocyte senescence. Cell. 2010, 141:717-727.
35. Shaw TJ, Martin P. Wound repair at a glance. J Cell Sci. 2009, 122:3209-3213.
36. Shelton DN, Chang E, Whittier PS, Choi D, Funk WD. Microarray analysis of replicative senescence. Curr Biol. 1999, 9:939-945.
37. Singer AJ, Clark RA. Cutaneous wound healing. N Engl J Med. 1999, 341:738-746.
38. Stramer BM, Mori R, Martin P. The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair. J Invest Dermatol. 2007, 127:1009-1017.
39. Telgenhoff D, Shroot B. Cellular senescence mechanisms in chronic wound healing. Cell Death Differ. 2005, 12:695-698.
40. Vande Berg JS, Rose MA, Haywood-Reid PL, Rudolph R, Payne WG, Robson MC. Cultured pressure ulcer fibroblasts show replicative senescence with elevated production of plasmin, plasminogen activator inhibitor-1, and transforming growth factor-beta1. Wound Repair Regen. 2005, 13:76-83.
41. Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell. 2008, 132:363-374.
42. Wajapeyee N, Serra RW, Zhu X, Mahalingam M, Green MR. Role for IGFBP7 in senescence induction by BRAF. Cell. 2010, 141:746-747.
43. Wynn TA. Cellular and molecular mechanisms of fibrosis. The Journal of Pathology. 2008, 214:199-210.
44. Xue W, Zender L, Miething C, Dickins RA, Hernando E, Krizhanovsky V, Cordon-Cardo C, Lowe SW. Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas. Nature. 2007, 445:656-660.
45. Young AR, Narita M. SASP reflects senescence. EMBO Rep. 2009, 10:228-230.